Skip to content
DraconiticResearch
Search Sources API
209,932 studies31 sourcesUpdated 14 min ago

Oncology

5,300 studies557 in 7 days2,546 in 30 days

Filters
Type
Date
Clear

Latest

5,300 studies

  1. Real-world perioperative FLOT delivery in gastric and gastro-oesophageal junction adenocarcinoma: a single-centre service evaluation in a District General Hospital in the UK
    R. Sabharwal, D. Bhaskaran
    medRxivPreprintCC BY-NC-NDFull textOncologymedRxiv
  2. The prospects and challenges of the use of cell-free DNA as a diagnostic and prognostic biomarker for oral cancer in Sub-Saharan Africa.
    Dennis Appiah Bolfrey, Dada Oluwaseyi Temilola, Mathew Owusu Boamah +2
    The journal of liquid biopsyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  3. Circulating miRNA-21 and Biomarkers of Inflammation, Fibrosis, and Oxidative Stress in Adults with Type 2 Diabetes Mellitus: A Cross-Sectional Study.
    Pringgodigdo Nugroho, Angeline Tancherla, Em Yunir +4
    Diabetes, metabolic syndrome and obesity : targets and therapyPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  4. AgeX trials of extending the breast screening age range: study protocol for the follow-up phase (2025–2033)
    The AgeX Investigators, Abdel Babiker, Stephen MacMahon +23
    TrialsPeer-reviewedCC BY 4.0OncologyCrossref
  5. Epigenetic regulation of cancer stem cell plasticity and relapse competence in EGFR-mutant lung cancer
    Xiangxiang Sun, Shengshan Xu, Qian Guo
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  6. Application of orthopedic robotics in cancer surgery: integrating precision treatment and postoperative exercise rehabilitation
    Jing Wang, Qin Xuan, Zhenyu Yang +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  7. Mechanisms of resistance to immune checkpoint inhibitors in renal cell carcinoma and novel treatment strategies
    Li Chen, Jie Cheng, Shilong Mao
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefPMC
  8. Evidence and clinical implications of target antigen changes and reassessment after ADC therapy in solid tumors
    Zhao Wang, Yunze Shi, Songjiang Liu
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  9. Malignant remodeling of the bone marrow microenvironment in acute myeloid leukemia: mechanisms and therapeutic implications
    Wenhao Xu, Qing Han, Changrong Sun +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  10. Case Report: Primary splenic angiosarcoma: a case report and literature review
    Jinqin Zha, Hang Zhou, Hao Yin +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  11. Oral versus intravenous melphalan for autologous stem cell transplantation conditioning in lymphoma and multiple myeloma: a retrospective cohort study
    Jingrong Wang, Yimeng Guo, Jin Zhao +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  12. Intraoperative model-guided anchor placement with CT verification for non-percutaneous localization of small pulmonary nodules: a retrospective feasibility study
    Xining Zhang, Jingwei Liu, Shijie Zhang +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  13. Three-year trajectories of insomnia symptoms among young breast cancer survivors
    Chloe M. Hery, Kayla Williams, Sarah A. Janse +6
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  14. Exploring the potential mechanisms of Pei Yuan Yi Fei decoction for non-small cell lung cancer through network pharmacology and experimental validation
    Yingjia Zhou, Jia Wu, Mei Li +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  15. Sex-associated differences in initial resection location, margin status, and re-excision in extremity leiomyosarcoma: a retrospective tertiary-center cohort study
    Pia Weskamp, Sonja Verena Schmidt, Marius Drysch +5
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  16. Efficacy and safety of apatinib-containing neoadjuvant regimens for resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and single-arm meta-analysis
    Kaiyi Xin, Zhilu Chen, Liu Yang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  17. Macroscopic versus rapid on-site evaluation for EUS-guided tissue acquisition of solid pancreatic masses: a systematic review, diagnostic test accuracy meta-analysis, and network meta-analysis
    Huifang Xu, Jiongming He, Gong Chen +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  18. Exploring real-world unmet clinical needs among patients on first-line treatment with HER2-negative advanced gastric, gastroesophageal junction or esophageal adenocarcinoma in Asia, Europe and the United States
    Naureen Starling, Jaffer Ajani, Kohei Shitara +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  19. A pilot study of the impact of massage therapy on symptom burden during infusion in patients with cancer
    Christy DiCristofano, Marianne Razavi, Phi Hoang Tran +7
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  20. Early discordance between alpha-fetoprotein response and albumin-bilirubin deterioration refines response assessment in unresectable hepatocellular carcinoma receiving first-line immune-combination therapy: a real-world landmark cohort study
    Haitao Wu, Pengju Tang, Jinbo Gong +3
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  21. Case Report: Rapidly fatal hepatic portal venous gas following transarterial chemoembolization for hepatocellular carcinoma
    Renshan Zhao, Bin Xie
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  22. Temporal variation in initial UICC stage and post-diagnostic treatment intervals in patients with oral squamous cell carcinoma in Saxony before and during the COVID-19 pandemic
    Gerald Stach, Günter Lauer, Samaneh Farahzadi +2
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  23. Application of semidefinite programming approach for detection of genomic copy number variations from peripheral blood in ovarian cancer
    Michael Kalab, Arunabh Sharma, Anastasia Klopf +11
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  24. Shenqi Shiyiwei Granule for breast cancer related fatigue-centered symptom cluster: protocol of a multicenter randomized double-blind placebo-controlled trial
    Si-Yuan Li, Tong-Tong Wu, Yu-Xuan Zhang +4
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC
  25. Recurrent aneurysmal fibrous histiocytoma of the breast with malignant features: a rare case report
    Kui Xiao, Nianqu Zhang, Qing Li +1
    Frontiers in OncologyPeer-reviewedCC BY 4.0Full textOncologyCrossrefEurope PMCPMCEurope PMC